Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5718-5726

  Kozako, Tomohiro ^a   Arima, Naomichi ^a   Toji, Shingo ^c   Masamoto, Izumi ^a   Akimoto, Masaki ^a   Hamada, Heiichiro ^b   Che, Xiao Fang ^a   Fujiwara, Hiroshi ^b   Matsushita, Kakushi ^b   Tokunaga, Masahito ^a   Haraguchi, Koichi ^a   Uozumi, Kimiharu ^a   Suzuki, Susumu ^a   Takezaki, Toshiro ^a   Sonoda, Shunro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^c Medical & Biological Laboratories Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; GRANZYME B; HLA A ANTIGEN; HLA ANTIGEN; PERFORIN; TAX PROTEIN; TETRAMER; VIRUS ENVELOPE PROTEIN;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CD8+ T LYMPHOCYTE; CELL CLONE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IN VIVO STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T CELL LEUKEMIA;

EID: 33749568853     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5718     Document Type: Article

References (50)

1. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492.
2. Popovic, M., M. S. Reitz, Jr., M. G. Sarngadharan, M. Robert-Guroff, V. S. Kalyanaraman, Y. Nakao, I. Miyoshi, J. Minowada, M. Yoshida, Y. Ito, and R. C. Gallo. 1982. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature 300: 63-66.
3. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79: 2031-2035.
4. de The, G., and R. Bomford. 1993. An HTLV-1 vaccine: why, how, for whom? AIDS Res. Hum. Retroviruses 9: 381-386.
5. Tajima, K. 1990. The 4th nation-wide study of adull T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features: the T- and B-Cell Malignancy Study Group. Int. J. Cancer 15: 237-243.
6. Yamada, Y., M. Tomonaga, H. Fukuda, S. Hanada, A. Utsunomiya, M. Tara, M. Sano, S. Ikeda, K. Takalsuki, M. Kozuru, et al. 2001. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br. J. Haematol. 113: 375-382.
7. Borg, A., J. A. Yin, P. R. Johnson, J. Tosswill, M. Saunders, and D. Morris. 1996. Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br. J. Haematol. 94: 713-715.
8. Utsunomiya, A., Y. Miyazaki, Y. Takatsuka, S. Hanada, K. Uozumi, S. Yashiki, M. Tara, F. Kawano, Y. Saburi, H. Kikuchi, et al. 2001. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 27: 15-20.
9. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248.
10. Mitsuya, H., L. A. Matis, M. Megson, P. A. Bunn, C. Murray, D. L. Mann, R. C. Gallo, and S. Broder. 1983. Generation of an HLA-restricted cytoxic T cells reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus. J. Exp. Med. 158: 994-999.
11. + cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 3: 761-767.
12. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386-1392.
13. Kannagi, M., N. Harashima, K. Kurihara, T. Ohashi, A. Utsunomiya, R. Tanosaki, M. Masuda, M. Tomonaga, and J. Okamura. 2005. Tumor immunity against adult T-cell leukemia. Cancer Sci. 96: 249-255.
14. + T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia 18: 126-132.
15. Uchiyama, T. 1997. Human T cell leukemia virus type I (HTLV-I) and human diseases. Ann. Rev. Immunol. 15: 15-37.
16. Usuku, K., S. Sonoda, M. Osame, S. Yashiki, K. Takahashi, M. Matsumoto, T. Sawada, K. Tsuji, M. Tara, and A. Igata. 1988. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann. Neurol. 23(Suppl.): S143-S150.
17. Motomura, M., T. Nakamura, K. Nagasato, K. Shibayama, S. Kubo, I. Nakasono, M. Tsujihata, S. Sonoda, and S. Yashiki. 1990. HTLV-I associated myelopathy in an identical twin. Lancet 336: 55.
18. Sonoda, S., T. Fujiyoshi, and S. Yashiki. 1996. Immunogenetics of HTLV-I/II and associated diseases. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1): S119-S123.
19. + cytotoxic T lymphocytes. AIDS Res. Hum. Retroviruses 17: 1047-1061.
20. Harashima, N., K. Kurihara, A. Utsunomiya, R. Tanosaki, S. Hanabuchi, M. Masuda, T. Ohashi, F. Fukui, A. Hasegawa, T. Masuda, et al. 2004. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 64: 391-399.
21. Parker, C. E., S. Nightingale, G. P. Taylor, J. Weber, and C. R. Bangham. 1994. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type 1-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol. 68: 2860-2868.
22. Freedman, L. R., J. C. Cerottini, and K. T. Brunner. 1972. In vivo studies of the role of cytotoxic T-cells in tumor allograft immunity. J. Immunol. 109: 1371-1378.
23. Roden, M. M., K. H. Lee, M. C. Panelli, and F. M. Marincola. 1999. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J. Immunol. Methods 226: 29-41.
24. Setoyama, M., Y. Katahira, T. Hamada, M. Tashiro, S. Yashiki, Y. Tanaka, H. Tozawa, and S. Sonoda. 1992. Expression of human T-cell lymphotropic virus type-1 gene products in the short-term cultured skin tissues of an adult T-cell leukemia/lymphoma patient with cutaneous manifestations. J. Dermatol. 19: 133-139.
25. Arima, N., K. Matsushita, H. Obata, H. Ohtsubo, H. Fujiwara, K. Arimura, T. Kukita, Y. Suruga, S. Wakamatsu, S. Hidaka, and C. Tei. 1999. NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp. Hematol. 27: 1168-1175.
26. Yoshida, M. 2001. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19: 475-496.
27. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308.
28. + T cell effector activity is dictated by cognate peptide concentration. J. Immunol. 172: 6407-6417.
29. 11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J. Immunol. 162: 1765-1771.
30. + T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections. Nat. Med. 9: 469-476.
31. + T lymphocytes. J. Immunol. 167: 181-187.
32. Shimoyama, M. 1991. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79: 428-437.
33. Osame, M., M. Nakagawa, F. Umehara, S. Ijichi, T. Moritoyo, I. Higuchi, K. Usuku, K. Arimura, and S. Izumo. 1997. Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV. J. Neurovirol. 3(Suppl. 1): S50-S51.
34. Sonoda, S. 2003. Genetic risk of disease development among HTLV-1 carriers. Gann Monogr. Cancer Res. 50: 289-301.
35. Katahira, Y., S. Yashiki, T. Fujiyoshi, K. Nomura, M. Tara, M. Mori, M. Setoyama, T. Kanzaki, H. Shida, and S. Sonoda. 1995. In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. Jpn. J. Cancer Res. 86: 21-27.
36. Itoh, Y., N. Mizuki, T. Shimada, F. Azuma, M. Itakura, K. Kashiwase, E. Kikkawa, J. K. Kulski, M. Satake, and H. Inoko. 2005. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 717-729.
37. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
38. Bodinier, M., M. A. Peyrat, C. Tournay, F. Davodeau, F. Romagne, M. Bonneville, and F. Lang. 2000. Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CDS binding. Nat. Med. 6: 707-710.
39. Haanen, J. B., M. G. van Oijen, F. Tirion, L. C. Oomen, A. M. Kruisbeek, F. A. Vyth-Dreese, and T. N. Schumacher. 2000. In situ detection of virus- and tumor-specific T-cell immunity. Nat. Med. 6: 1056-1060.
40. Skinner, P. J., M. A. Daniels, C. S. Schmidt, S. C. Jameson, and A. T. Haase. 2000. Cutting edge: in situ tetramer staining of antigen-specific T cells in tissues. J. Immunol. 165: 613-617.
41. + T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98: 1872-1881.
42. Lecoeur, H., E. Ledru, M. C. Prevost, and M. L. Gougeon. 1997. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J. Immunol. Methods 209: 111-123.
43. Sonoda, J., C. Koriyama, S. Yamamoto, T. Kozako, H. C. Li, C. Lema, S. Yashiki, T. Fujiyoshi, M. Yoshinaga, Y. Nagata, et al. 2004. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers in diminished by green tea drinking. Cancer Sci. 95: 596-601.
44. Prussin, C., and D. D. Metcalfe. 1995. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies, J. Immunol. Methods 188: 117-128.
45. Rubio, V., T. B. Stuge, N. Singh, M. R. Berts, J. S. Weber, M. Roederer, and P. P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9: 1377-1382.
46. Burkett, M. W., K. A. Shafer-Weaver, S. Strobl, M. Baseler, and A. Malyguine. 2005. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity. J. Immunother. 28: 396-402.
47. Bangham, C. R. 2003. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J. Gen. Virol. 84: 3177-3189.
48. Taylor, G. P., and M. Matsuoka. 2005. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 24: 6047-6057.
49. Marin, O., K. Hasui, C. Remondegui, E. Sato, M. M. Aye, N. Takenouchi, S. Izumo, and K. Tajima. 2002. Adult T-cell leukemia/lymphoma in Jujuy, northwest Argentina. Pathol. Int. 52: 348-357.
50. + lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J. Immunol. 161: 482-488.